Abstract-The specific role of endogenous glutathione in response to neuronal degeneration induced by trimethyltin (TMT) in the hippocampus was examined in rats. A single injection of TMT (8 mg/kg, i.p.) produced a rapid increase in the formation of hydroxyl radical and in the levels of malondialdehyde (MDA) and protein carbonyl. TMT-induced seizure activity significantly increased after this initial oxidative stress, and remained elevated for up to 2 weeks post-TMT. Although a significant loss of hippocampal Cornus Ammonis CA1, CA3 and CA4 neurons was observed at 3 weeks post-TMT, the elevation in the level of hydroxyl radicals, MDA, and protein carbonyl had returned to near-control levels at that time. In contrast, the ratio of reduced to oxidized glutathione remained significantly decreased at 3 weeks post-TMT, and the glutathione-like immunoreactivity of the pyramidal neurons was decreased. 
Acute exposure to trimethyltin (TMT) produces a behavioral syndrome in adult rats that includes aggression, hyperirritability, tremor, convulsive/epileptic episodes, and hyperactivity combined with learning deficiencies (Dyer et al., 1982) . TMT selectively damages neuronal populations in the brain, especially in the hippocampal formation (Brown et al., 1979) . TMT exposure leads to a loss of N-methyl-D-aspartate (NMDA) and kainate (KA) receptors in the limbic system (Andersson et al., 1995) , which implies that the neurodegenerative effect of TMT involves increased extracellular glutamate levels and overstimulation of excitatory amino acid receptors (Koczyk and Jablonska, 1998) . Moreover, it is known that the activation of NMDA and KA receptors results in the generation of toxic amounts of free radicals (Carriedo et al., 1998; LafonCazal et al., 1993) . Therefore, it is plausible to hypothesize that the formation of reactive oxygen species (ROS) is one of the underlying mechanisms responsible for TMTinduced neurodegeneration.
Although TMT exposure is known to increase ROS production in mouse brains (as measured by dichlorofluorescein assays) (Ali et al., 1992) , the possible roles of oxidative stress and endogenous antioxidant status in TMT-induced neurodegeneration require further elucidation.
Free radicals probably cause cell damage by inducing lipid peroxidation in cell membranes (Siesjo et al., 1989) . Lipid peroxidation results from an attack by hydroxyl radicals (Ȯ H) on the phospholipid side chains in cell membranes. TMT increases the free intracellular Ca 2ϩ concentration by promoting the influx of extracellular Ca 2ϩ and the release of Ca 2ϩ from intracellular stores (Fechter and Liu, 1995; Komulainen and Bondy, 1987) . This increased Ca ϩ2 concentration activates proteases and other degradative enzymes, which in turn promotes the conversion of xanthine dehydrogenase to xanthine oxidase, initiating the production of superoxide radicals (Ȯ 2 Ϫ ). In addition, Ȯ 2 Ϫ can react directly with nitric oxide to form peroxynitrite anions (ONOO Ϫ ), which are protonated at cellular pH to produce peroxynitrous acid (HONOO), which rapidly forms Ȯ H (Oury et al., 1993) .
Cells possess several different compounds that can function in the elimination of hydrogen peroxide and organic peroxides as well as the detoxification of foreign compounds. The most important one of these compounds is glutathione (Meister and Anderson, 1983; Bains and Shaw, 1997) . Glutathione plays a crucial role as a free radical scavenger that is particularly effective against ·OH. The ability of glutathione to nonenzymatically scavenge both singlet oxygen and ·OH provides a first line of antioxidant defense. Glutathione is the most prevalent intracellular thiol in mammalian tissues, including the CNS, and participates in a variety of biochemical pathways. It protects cell membranes against peroxides by acting as a free-radical scavenger and by serving as a coenzyme in several reactions (Bains and Shaw, 1997) .
Abnormalities in glutathione synthesis can result in neurological disorders (Bains and Shaw, 1997; Schweizer et al., 2004) , and recent studies have suggested that membrane lipid peroxidation may be involved in epileptogenesis in some experimental models of epilepsy (Kim et al., 1997 (Kim et al., , 2000c (Kim et al., , 2002a Singh and Pathak, 1990; Willmore et al., 1986) . The production of epileptiform discharges in some forms of experimental epilepsy/convulsion is believed to be mediated by membrane lipid peroxidation initiated by the action of oxygen radicals, which can alter electrophysiologic properties of membranes, such as iongating (Pellmar, 1986) .
In this study, therefore, we examined the formation of the hydroxyl radicals, malondialdehyde (MDA; a marker of lipid peroxidation), and protein carbonyl (a marker of protein oxidation) in the hippocampus of TMT-treated rats. In addition, we examined the status of the glutathionemediated antioxidant systems by determining the ratio of reduced glutathione (GSH) versus oxidized glutathione (GSSG) in the hippocampus, as well as the immunocytochemical distribution of glutathione (Hjelle et al., 1994) , and the expression levels of glutathione peroxidase (GPX) and glutathione reductase (GRX). In all of these experiments, we also evaluated the effects of ascorbic acid treatment on the TMT-induced neurotoxicity to determine whether oxidative stress was involved in the cellular damage induced by this neurotoxin.
EXPERIMENTAL PROCEDURES

Treatment of animals
All animals were treated in strict accordance with the National Institutes of Health (NIH) Guide for the Humane Care and Use of Laboratory Animals (NIH Publication No. 85-23, 1985 ; ww.dels. nas.edu/ila). This study was reviewed and approved by the animal care and use committee of Kangwon National University and was performed in accordance with ILAR guidelines for the care and use of laboratory animals. As preliminary studies indicated that older Sprague-Dawley (S-D) rats were more susceptible to seizures and oxidative stresses induced by TMT (Suh et al., 1999) , this study was performed with 16-month-old male S-D rats (Bio Genomic, Inc./Charles River Technology, Gapyung-Gun, Gyeonggi-Do, Korea). They were maintained on a 12-h light/dark cycle and fed ad libitum, and were allowed to adapt to these conditions for 2 weeks before TMT administration (8 mg/kg, i.p.). Ascorbate (50 or 100 mg/kg, p.o.) was given twice, 6 h apart. Thirty minutes after the second dose of ascorbate, TMT was administered. Rats were received ascorbate once a day for 3 weeks after TMT administration. Control rats received an equal volume of saline. The time courses for kill are as follows; 1 h, 4 h, 24 h, 48 h, 1 week, 2 weeks, and 3 weeks post-TMT. Rats were killed at 30 min after every ascorbate administration since first two time courses for kill (1 h and 4 h after TMT injection).
Determination of seizure activity
Using a convulsion meter (CONVULS-1, Columbus Instruments, Columbus, OH, USA) (Kim et al., 2002a) , the seizure activity over a 20-min period was measured at 1 h, 2 h, 4 h, 1 day, 2 days, 3 days, 4 days, 1 week, 2 weeks, and 3 weeks after TMT treatment.
Determination of hydroxyl radical
Rats were anesthetized with pentobarbital (50 mg/kg) and perfused transcardially with ice-cold 0.9% NaCl (80 ml/100 g) to remove free radical scavengers and free radical sources in the brain (Kim et al., 2000a,c) . The brains were rapidly removed, and hippocampal tissues were dissected and stored at Ϫ70°C. TMT, 2,3-dihydroxybenzoic acid (2,3-DHBA) and 2,5-dihydroxybenzoic acid (2,5-DHBA) were obtained from Aldrich (Milwaukee, WI, USA). Sodium salicylate was purchased from Sigma (St. Louis, MO, USA). All other reagents were of the highest grade commercially available. All drug solutions were made fresh in distilled deionized water.
To measure hydroxyl radicals, animals were injected with sodium salicylate (100 mg/kg, i.p.) 30 min before decapitation and dissection. Each hippocampal sample was then homogenized with 0.1 N HClO 4 containing 10% methanol in a vortex mixer for 2 min. The homogenate was centrifuged for 2 min at 14,000 r.p.m., and then the supernatant (100 l) was injected onto aBondapak C 18 column. The eluent conditions included a mobile phase (pH 4.75) consisting of 50 mM sodium phosphate dihydrate (monobasic), 1 mM disodium EDTA, 10 mM NaCl, 10% (v/v) acetonitrile, and 6% (v/v) methanol. The flow rate was 0.7 ml/min and the column was maintained at ambient room temperature. 2,3-DHBA and 2,5-DHBA were measured electrochemically (LC-4C Amperometric Detector, Bioanalytical Systems Inc, Lafayette, IN, USA) using a glass carbon working electrode vs. a Ag/AgCl reference electrode maintained at a potential of 530 mV (Giovanni et al., 1995) . The data were expressed as the ratio of DHBA to salicylate in order to normalize DHBA levels to differing brain concentrations of salicylate (Hall et al., 1993) .
Determination of MDA
The amount of lipid peroxidation was determined by measuring the accumulation of thiobarbituric acid-reactive substances in homogenates of hippocampal tissue and is expressed as MDA content (Jareno et al., 1998; Kim et al., 1999b Kim et al., , 2000c Kim et al., , 2002a . In brief, 0.1 ml of the homogenate (or standard solutions prepared daily from 1,1,3,3-tetra-methoxypropane) and 0.75 ml of the working solution (thiobarbituric acid 0.37% and perchloric acid 6.4%, 2:1 v/v) were mixed and heated to 95°C for 1 h. After cooling (10 min in ice water bath), the flocculent precipitate was removed by centrifugation at 3200ϫg for 10 min. The supernatant was neu-tralized and filtered prior to injection on an ODS 5 m column. Mobile phase consisted of 50 mM PBS (pH 6.0):methanol (58:42, v/v). Isocratic separation was performed with 1.0 ml/min flow rate and detection at 532 nm using a UV/VIS HPLC-Detector (Model 486, Waters Associates, Milford, MA, USA).
Determination of protein carbonyl
The extent of protein oxidation was assessed by measuring the content of protein carbonyl groups, which was determined spectrophotometrically with the 2,4-dinitrophenylhydrazine (DNPH)-labeling procedure (Kim et al., 1997 (Kim et al., , 2000c (Kim et al., , 2002a as described by Oliver et al. (1987) . The results are expressed as nmol of DNPH incorporated/mg protein based on the extinction coefficient (21 mM Ϫ1 cm Ϫ1 ) for aliphatic hydrazones. Protein was measured using the BCA protein assay reagent (Pierce, Rockford, IL, USA).
Determination of GSH and GSSG
GSH and GSSG were immediately measured from dissected hippocampal tissues by the method described by Reed et al. (1980) with minor modification (Kim et al., 1999b (Kim et al., , 2000c . Briefly, a sample of the acidified supernatant was added to the internal standard (1 mM cysteic acid) and 0.88 M iodoacetic acid. Excess potassium hydrogen bicarbonate was added to the reaction to precipitate potassium perchlorate. Subsequently 0.5 ml of an alcoholic solution of 1.5% (v/v) 2,4-dinitrofluorobenzene was added to the samples and incubated for 4 h. Diethyl ether (1.0 ml) was added and the samples were shaken and centrifuged at 2000ϫg for 20 min at room temperature. The residual aqueous phase containing derived glutathione was separated and analyzed by HPLC. Separation of 5-carboxymethyl glutathione was carried out at room temperature with a flow rate of 1.2 ml/min. Chromatographic separation of derivatives was performed by injecting samples (10 l) of the aqueous phase onto a Spherisorb S-5 amino ODS column. Glutathione was subsequently detected using a UV detector at 365 nm. Glutathione derivatives (GSH and GSSG) were quantified in relation to the internal standard (cysteic acid).
Glutathione immunocytochemistry
Animals were killed at 4 h, 48 h and 3 weeks after TMT-treatment (nϭ5 at each time-point in each treatment group). They were deeply anesthetized with pentobarbital and perfused transcardially with 50 ml of 50 mM phosphate-buffered saline (PBS), followed by 500 ml of a mixture of 1% paraformaldehyde and 2.5% glutaraldehyde in PBS. The rate of perfusion was 50 ml/min. The brains were removed, post-fixed at 4°C for 2 h in the same fixative and then cryoprotected in 30% sucrose in PBS. The brains were cut on a horizontal sliding microtome into 40-m transverse freefloating sections. Immunocytochemistry was performed as described previously (Kim et al., 2000a,b) . Briefly, prior to incubation with the primary antibodies, sections were preincubated with 0.3% hydrogen peroxide in PBS for 30 min, then in PBS containing 0.4% Triton X-100 for 20 min and 1% normal serum for 20 min. After a 48 h incubation with the primary antibody (1:200) at 4°C, sections were incubated with the secondary biotinylated antisera for 1 h, and immersed in avidin-biotin-peroxidase complex for 1 h. 3,3=-Diaminobenzidine was used as a chromogen. The glutathione antibody (Hjelle et al., 1994; Ong et al., 2000; Kim et al., 2003) has been described elsewhere. Antibodies raised against GSH also recognized the oxidized form (Hjelle et al., 1994) . Thus, attempts to raise antibodies that react with GSSG but not with the reduced form have not met with success (Hjelle et al., 1994; Ong et al., 2000; Kim et al., 2003) . It is likely, however, that the reduced form is responsible for the major share of the immunocytochemical signal, as the reduced form is known to predominate over the oxidized form (Meister and Anderson, 1983; Meister 1994) .
Quantitative analysis for immunocytochemistry
The intensity of the immunoreactivity was graded as an absolute value using a computer-based image analysis system with a Polaroid digital microscopic camera [Optimas version 6.2; Neurolucida program: Additional contrast correcting system (Blue, Mirae-Ro system, Seoul, Korea) was added in order to compensate background signals] (Kim et al., 2000a (Kim et al., ,b, 2003 . For measurements of the immunoreactive populations, 25-30 cells were examined in each section. The areas examined were marked using a digital tablet and mouse. Within the areas, the immunoreactive cells were labeled and their x/y co-ordinates were recorded. The computer program then automatically calculated the immunoreactivity of the positive elements per mm 2 . These data were expressed as an absolute value of the immunoreactivity. Each value is the meanϮS.E.M. of five animals.
Double-labeling immunocytochemistry
Rats were transcardially perfused and post-fixed for 4 h in 4% paraformaldehyde. The brains were excised, cryoprotected in 30% sucrose, sectioned coronally (40 m) on a freezing microtome, and collected in cryoprotectant for storage at Ϫ20°C. Immunocytochemistry was conducted on free-floating brain sections as described previously (Kim et al., 2000a (Kim et al., ,b, 2002b . The sections were rinsed three times with PBS to remove cryoprotectant, and pre-incubated for 30 min in 0.1 M PBS with 1% bovine serum albumin and 0.2% Triton X-100. The sections were then incubated overnight with one of two combinations of primary antibodies: rabbit anti-glutathione (1:200) and mouse anti-OX-42 (a marker of microglia; 1:100), or rabbit anti-GSH (1:200) and mouse anti-antibody to glial fibrillary acidic protein (GFAP, a marker of astrocyte; 1:5000). The sections were then rinsed three times in 0.1 M PBS containing 0.01% Triton X-100 (PBS-T) and incubated with a combination of rhodamine-conjugated anti-rabbit IgG (1: 200) and FITC-conjugated anti-mouse IgG (1:200) for 1 h at room temperature. Tissues were then washed in PBS-T, mounted with Vectashield medium (Vector Laboratories, Burlingame, CA, USA). The tissues were viewed using a confocal laser microscope (Olympus FV300, Tokyo, Japan) and images were acquired by sequential scanning at the appropriate wavelengths. To analyze the localization of different antigens in double-stained samples, images were obtained from the same area and merged using the accompanying system software and Adobe Photoshop 7.0.
Western blot analysis
Rat brains were rapidly removed on ice. The hippocampus was homogenized and nuclear protein extracts were prepared. Forty micrograms of protein extract was separated on 12% sodium dodecyl sulfate/polyacrylamide gel, transferred onto nitrocellulose membranes and the resulting blot was blocked in PBS containing 3% skim milk for 30 min. Each blot was incubated overnight at 4°C with the antibody against GPX (Mirault et al., 1991; Trépanier et al., 1996; Kim et al., 2003) or GRX (Laboratory Frontier, Seoul, Korea; Son et al., 2000) at a 1:1000 dilution, respectively. After washing in PBS, membranes were incubated with a biotinylated goat anti-rabbit antibody for 1 h followed by incubation in avidinbiotin conjugated with horseradish peroxidase (Vectastatin Kit, Vector) at room temperature. The blots were then incubated in Enhanced chemiluminescence (ECL) reagent (Amersham, Arlington Heights, IL, USA), placed against Amersham hyperfilm and developed after a 2 min exposure. Relative intensities of the bands were quantified by laser densitometry (Kim et al., 2003; Son et al., 2000) .
Cresyl Violet-staining and neuron counts
Cresyl Violet-staining was performed in order to observe neuronal loss in the hippocampus induced by TMT. Neuron counts were made in areas of the CA1, CA3 and CA4. Only neurons with a visible nucleus and in which the entire outline of the cell was apparent were counted (Kim et al., 1999a; Shin et al., 2004 Shin et al., , 2005 . Every sixth section (200 m separation distance) was evaluated with a 63ϫ oil immersion objective on an Olympus microscope using a video camera and monitor (Kim et al., 1997 (Kim et al., , 2000c (Kim et al., , 2002a .
Statistics
Statistical analysis was performed by the one-way analysis of variance (ANOVA) with Duncan's new multiple range (DMR) test and Williams-Wilcoxon multiple rank sum test. A significant level of less than 0.05 was accepted for comparisons.
RESULTS
Ascorbate significantly attenuates TMT-induced seizures in a dose-dependent manner
Fifty-six out of 60 animals (93.3%) exhibited seizures after injection of TMT. The seizure activity steeply increased from 3 to 4 days post-TMT. This activity remained elevated at 2 weeks post-TMT, but almost no seizures were observed at 3 weeks. Although ascorbate did not prevent the initial convulsions (ratio of convulsing) after TMT administration, it inhibited the elevation of seizure activity in a dose-dependent manner (3 days and 4 days: SalineϩTMT vs. ascorbate 50 mg/kg or 100 mg/kgϩTMT, PϽ0.05 or PϽ0.01; Ascorbate 50 mg/kgϩTMT vs. 100 mg/kgϩTMT, PϽ0.05. 1 week and 2 weeks: SalineϩTMT vs. ascorbate 50 mg/kgϩTMT, PϽ0.05) (Fig. 1) .
Ascorbate significantly attenuates TMT-induced initial increases in hydroxyl radical formation in a dose-dependent manner
The production of hydroxyl radicals was determined by the salicylate trapping method. To compensate for changes in the production of hydroxylation products (dihydroxybenzoic acid derivatives, 2,3-DHBA and 2,5-DHBA), all data were expressed as the ratio of DHBA to salicylate (Carriedo et al., 1998) . Following the injection of TMT, the generation of 2,3-DHBA (Fig. 1A) paralleled that of 2,5-DHBA (Fig. 1B) . The formation of DHBA derivatives, and 2,5-DHBA in particular, increased significantly in the early stages following TMT administration; the generation of 2,3-DHBA and 2,5-DHBA remained significantly elevated for at least 48 h (1 h, PϽ0.01; 4 h, PϽ0.01; 24 h, PϽ0.05; 48 h, PϽ0.05 for 2,3-DHBA and 1 h, PϽ0.01; 4 h, PϽ0.01; 24 h, PϽ0.01; 48 h, PϽ0.05 for 2,5-DHBA vs. the levels at the corresponding time points in the control or ascorbate alone groups). This early elevation of DHBA levels diminished to near control levels by 1 week post-TMT. Treatment with ascorbate alone did not affect the formation of 2,3-DHBA or 2,5-DHBA; however, treatment with ascorbate (50 or 100 mg/kg) significantly attenuated the early increase in the formation of DHBA after TMT administration (for the ratio of 2,3-DHBA to salicylate: at 1 h and 4 h, 50 mg/kg or 100 mg/kg ascorbateϩTMT vs. SalineϩTMT, PϽ0.05 or PϽ0.01, respectively; 24 h and 48 h, 100 mg/kg ascorbateϩTMT vs. SalϩTMT, PϽ0.05, respectively; for the ratio of 2,5-DHBA to salicylate: 1 h, 100 mg/kg ascorbateϩTMT vs. SalineϩTMT, PϽ0.05; 4 h and 24 h, 50 mg/kg or 100 mg/kg ascorbateϩTMT vs. SalineϩTMT, PϽ0.05 or PϽ0.01, respectively; 48 h, 50 mg/kg or 100 mg/kg ascorbateϩTMT vs. SalineϩTMT, PϽ0.05 or PϽ0.05) in a dose-related manner (Fig. 2) .
Ascorbate significantly attenuates the initial TMT-induced increases in the levels of MDA and protein carbonyl in a dose dependent manner As was observed for DHBA, significant increases in the levels of MDA (Fig. 3A) and protein carbonyl (Fig. 3B (Fig. 3) .
Ascorbate significantly attenuates TMT-induced reduction of the GSH/GSSG ratio in a dose-dependent manner
No significant differences were observed in the content of GSH or GSSG or in the ratio of GSH/GSSG, between the groups treated with saline or ascorbate alone. After TMT administration, however, the GSH levels and the GSH/ GSSG ratios in the hippocampus decreased rapidly and remained depressed for 3 weeks (for GSH levels: 4 h, 24 h, 1 week, 2 weeks, and 3 weeks, PϽ0.05 vs. corresponding time point for the control or ascorbate-treated groups; 48 h, PϽ0.01 vs. the control or ascorbate; for GSH/GSSG ratios: 1 h, 4 h, 1 week, 2 week, and 3 weeks, PϽ0.05 vs. the corresponding time point for the control or ascorbatetreated groups; 24 h and 48 h, PϽ0.01 vs. the corresponding time point for the control or ascorbate-treated groups). In contrast, the GSSG level increased after TMT adminis- Fig. 2 . Effects of ascorbate on the production of hydroxyl radical in the rat hippocampus following TMT administration. The production of hydroxyl radicals is expressed as the ratio of 2,3-DHBA to salicylate (A) and the ratio of 2,5-DHBA to salicylate (B tration (4 and 48 h and 1 week, PϽ0.05 vs. the corresponding time point for the control or ascorbate-treated groups). Treatment with ascorbate prevented the TMTinduced decreases in the GSH level and GSH/GSSG ratio in the hippocampus in a dose-dependent manner (Fig. 4) .
Distribution of glutathione-immunoreactive cells in the rat hippocampus after TMT administration
In saline-treated control animals, there was a high intensity of glutathione-like immunoreactivity in the pyramidal cells and granule cells of dentate gyrus in the hippocampus (Fig. 5A and Table 1 ). In contrast, after TMT administration, the glutathione-like immunoreactivity was significantly reduced in the stratum pyramidale (SP) of the CA1, CA3 and CA4 regions (4 h and 48 h, PϽ0.05 vs. saline-treated group) without significant neuronal losses at 4 h and 48 h (Fig. 5B, D) . Treatment with ascorbate (100 mg/kg) attenuated the TMT-induced reductions in glutathione-like immunoreactivity (CA3 and CA4 regions: 4 h, PϽ0.05 vs. SalineϩTMT group; CA1, CA3 and CA4: 48 h, PϽ0.05 vs. SalineϩTMT group). Three weeks after the administration of TMT, there was a significant loss of neuronal cells in the CA1 (PϽ0.01 vs. saline), CA3 (PϽ0.01 vs. saline) and CA4 (PϽ0.01 vs. saline) regions; thus, most glutathione-immunopositive neurons in these regions had also been lost by 3 weeks post-TMT (Fig. 5F ), whereas the appearance of glutathione-positive non-neuronal populations was noted in the stratum radiatum (SR) at the same time point (Fig. 5F ). Treatment with ascorbate (50 mg/kg or 100 mg/kg) attenuated the TMTinduced neuronal losses mainly in the CA1 and CA3 regions (ascorbate 50 or 100 mg/kgϩTMT vs. salineϩTMT, PϽ0.05 or PϽ0.01) and the appearance of glutathionepositive non-neuronal populations (ascorbate 100 mg/kgϩ TMT vs. salineϩTMT, PϽ0.01) in a dose-dependent manner (Table 1, Fig. 5G, H) .
Glutathione-immunoreactivity occurs in astrocyte-like cells and co-localizes with GFAP-immunoreactivity after TMT administration
Double-labeling immunocytochemical experiments demonstrated that the glutathione-positive cells that appeared in the SR at 3 weeks after the administration of TMT were reactive astrocytes. These cells had red fluorescence in the cell bodies, indicative of glutathione reactivity, and green fluorescence in the astrocytic processes, indicative of GFAP-immunoreactivity. Although the anatomical sites of activated microglia as indicated by OX-42 staining, overlapped with those of the glutathione-positive cells, the distribution of the two cell populations was dissimilar (Fig. 6) .
Ascorbate significantly attenuates TMT-induced reduction of the expression levels of GPX and GRX in the hippocampus in a dose-dependent manner
Western immunoblot analysis of nuclear extracts from the hippocampus revealed that the expression of GPX protein was largely unaffected in the ascorbate-treated group as compared with the saline controls. However, after TMT administration, large and significant reductions in GPX expression were noted at 4 h (PϽ0.05 vs. saline group), 48 h (PϽ0.01 vs. saline group), and 3 weeks post-TMT (PϽ0.01 vs. saline group). These reductions were attenuated in treatment with ascorbate (4 h: ascorbate 100 mg/ kgϩTMT vs. salineϩTMT, PϽ0.05; 48 h: ascorbate 50 or 100 mg/kgϩTMT vs. salineϩTMT, PϽ0.05 or PϽ0.01; 3 weeks: ascorbate 50 or 100 mg/kgϩTMT vs. salineϩTMT, PϽ0.05 or PϽ0.01, respectively) (Fig. 7A) .
Similarly, the expression of GRX protein, as determined by Western immunoblot analysis, was not altered by treatment with ascorbate compared with the controls. However, after TMT administration, significant reductions were observed at 4 h (PϽ0.05 vs. saline group) and 48 h (PϽ0.01 vs. saline group), and 3 weeks post-TMT (PϽ0.05 vs. saline group). These reductions were attenuated by treatment with ascorbate (4 h: ascorbate 100 mg/ kgϩTMT vs. salineϩTMT, PϽ0.05; 48 h: ascorbate 100 mg/kgϩTMT vs. salineϩTMT, PϽ0.05; 3 weeks: ascorbate 50 or 100 mg/kgϩTMT vs. salineϩTMT, PϽ0.05 or PϽ0.01 respectively) (Fig. 7B) .
Ascorbate significantly attenuates TMT-induced neuronal losses in a dose-dependent manner
Treatment with ascorbate did not change the cellular architecture in the pyramidal layer of the hippocampus compared with saline controls. Three weeks after TMT administration, significant neuronal losses were noted in the CA1, CA3, and CA4 (PϽ0.01) regions of the hippocampus. Treatment with ascorbate significantly prevented the TMT-induced neuronal losses in a dosedependent manner (CA1: 50 mg/kg or 100 mg/kg of ascorbateϩTMT vs. salineϩTMT, PϽ0.05 or PϽ0.01; CA3: 50 mg/kg or 100 mg/kg of ascorbateϩTMT vs. salineϩTMT, PϽ0.05 or PϽ0.01, 100 mg/kg ascorbateϩ TMT vs. 50 mg/kg ascorbateϩTMT, PϽ0.05; CA4: 100 mg/kg ascorbateϩTMT vs. salineϩTMT, PϽ0.01, 100 mg/kg ascorbateϩTMT vs. 50 mg/kg ascorbateϩ TMT, PϽ0.05) (Fig. 8) .
DISCUSSION
This study clearly demonstrated that the systemic administration of TMT results in a significant increase in the formation of hydroxyl radicals, MDA, and protein carbonyl in the hippocampus of the rat. These changes were most pronounced in the early stages after TMT administration. These findings agree with the results of Ali et al. (1992) , who showed that ROS are elevated in the mouse hippocampus in the early stages (24 h and 48 h) after injection of TMT. More importantly, TMT induced a persistent disruption of glutathione homeostasis; the ratio of reduced to GSSG, the glutathione-like immunoreactivity, and the expression levels of GPX and GRX proteins were all decreased in the rat hippocampus. We have also demonstrated that the treatment with ascorbate attenuated TMT-induced neurotoxic changes, as seen in seizure activity and in changes of all biomarkers. This suggests that TMT produced the neurotoxic insult, at least in part, via oxidative stress in the brain.
TMT produces relatively selective neuronal damage, similar to that produced by kainic acid (KA), an excitotoxic analog of glutamate. Although TMT and KA have different time courses for the induction of seizures and pathologic changes (Sloviter et al., 1986) , the two agents could share a common mechanism for the production of the observed hippocampal lesions. Both TMT and KA intoxication are reported to result in behavioral symptoms that include seizures, which may be related to their interaction with the activators of the endogenous excitatory transmitter systems (Kim et al., 1999a; Patel et al., 1990; Sperk, 1994; Sun et al., 1997) .
It has been recognized that decreases in GABA A receptor subunit and in GABA B receptor mRNA levels in sector CA3 may be a consequence of loss of CA3 neurons manifested after TMT treatment (Nishimura et al., 2001 ). The decreases observed in GABA A receptor subunit ␣2 mRNA preceded this neurotoxin-induced cell loss. Further- Each value for intensity of glutathione-like immunoreactivity was graded as an absolute value using image analysis systems (Kim et al., 2003 more, ␣2 mRNA may be down-regulated during the pathogenic process. Thus, we cannot rule out the possibility that the increased neuronal activity/injury after TMT treatment might be the result in part of the attenuation of the inhibitory GABAergic system. Brain-derived neurotropic factor (BDNF) is a well-known component of injury-induced compensatory responses. The CA3 region does not exhibit a compensatory change in BDNF production and, accordingly, is vulnerable to degeneration in the TMT-treated rat. For this reason, the pyramidal cells of the CA3 and CA4 (CA3c) hippocampal subfields appear to be particularly sensitive to acute toxicity from a single dose of TMT (Dyer et al., 1982) . Recently, we have reported that lipid peroxidation and protein oxidation return to near control levels by 2 days after KA treatment in the rat (Kim et al., 1997 (Kim et al., , 2000c (Kim et al., , 2002a . We found similar results in the present study, demonstrating that lipid peroxidation, protein oxidation, and the formation of hydroxyl radicals recovered to control levels by 2 days post-TMT. In contrast, the GSH/GSSG ratio and the expression levels of GPX and GRX proteins remained significantly decreased for up to 3 weeks post-TMT. These findings suggest that endogenous free radical scavengers, including the glutathione-related system, cannot adapt rapidly in response to oxidative stress following neurotoxic insults, whereas the exogenous free radical scavenger, ascorbic acid, is able to neutralize oxidative damage as demonstrated in this study and others (Meister, 1994) .
Another plausible explanation for our finding is that the levels of lipid peroxidation, protein carbonyl formation, and hydroxyl radical generation found in the severe neuronal lesion following challenge with TMT reflect different degrees of oxidative stress in neurons and glial cells, or are attributable to changes in the levels of antioxidant enzyme activity in the cells that remain in the damaged region (Kim et al., 2000a,b,c) . Further, studies are needed to fully understand this phenomenon.
GSH is synthesized and degraded in most cell types by a series of well-characterized enzymatic reactions. It exists in both reduced form (GSH) and as an oxidized dimer (GSSG). The former is the largest fraction by far in physiological conditions (Bains and Shaw, 1997; Kim et al., 2000c) . GSH and GSSG are interconvertible by the actions of two enzymes, GPX and GRX. GSH strongly modulates the redox state (the ratio of oxidizing to reducing equivalents) of the cell, a role which is critical for cell survival (Bains and Shaw, 1997) . GSSG is formed in antioxidant reactions that involve GSH and can accumulate when oxidative processing is increased in the cell. The GSSG/ Fig. 7 . The effects of ascorbate on TMT-induced changes in GPX and GRX expression in the rat hippocampus. Nuclear extracts from hippocampus were prepared at 4 h, 48 h, and 3 weeks after TMT administration and were examined by Western blot analysis. Western blots were probed with antibody to the 21-kDa GPX protein (A) or the 56-kDa GRX protein (B GSH ratio thus serves as a sensitive index of oxidative stress (Toborek and Hennig, 1994; Kim et al., 2000c Kim et al., , 2003 . GSSG is reduced to regenerate GSH in a reaction catalyzed by GRX and requiring reduced nicotinamide adenine dinucleotide phosphate (NADPH) as a hydrogen donor (Toborek and Hennig, 1994; Bains and Shaw, 1997) . A particularly important function of both ascorbate and GSH in neurons might be their ability to nonenzymatically neutralize reactive hydroxyl radicals, because there are no cellular enzymes analogous to superoxide dismutase or GPX that could scavenge ·OH (Cohen, 1994) . In addition, ascorbate and GSH can interact as a redox couple (Meister, 1994) . A depletion of either ascorbate or GSH can be compensated by the continued presence of the other. For example, administration of GSH ester can prevent the onset of scurvy in ascorbate-deficient guinea-pigs, whereas ascorbate administration can prevent tissue damage from occurring after inhibition of GSH synthesis (Meister, 1994) .
Ascorbate is unable to cross the blood-brain barrier at the level of the brain capillaries (Spector, 1981) , but it can enter the neuropil via a saturable two-stage system. The first system is an active transporter in the choroid plexus (Sharma et al., 1963; Siesjo et al., 1989; Spector, 1981) , and the second system is at the level of the plasma membrane (Sharma et al., 1963) . Within the brain, however, ascorbate levels are not homogenous; in humans, the highest levels are found in the hippocampus, amygdala, and hypothalamus (Hornig, 1975) . Although the temporal window of neuroprotection owing to ascorbate treatment is considerably shorter than that reported for other protectants, such as dizocilpine or R-phenylisopropyladenosine MacGregor et al., , 1996 , the protective activity of ascorbate under our experimental conditions might be the result of its strong ability to scavenge free radicals. Here, we reported that exogenous ascorbate prevents TMT-induced increases in neuronal degeneration in the hippocampus via the attenuation of oxidative stress during the early stages. Consistent with our findings, Bannon et al. (1993) demonstrated that the administration of low-level ascorbate inhibited TMT-induced learning impairment in rats. Oxidized ascorbate can be reduced and then recycled by GSH and other intracellular thiols, and, in some cells, by a GSH-dependent dehydroascorbate reductase (Rose, 1993) . Therefore, although ascorbate can act as a pro-oxidant in vitro (Rice, 2000) , antioxidant ascorbate appears to be an essential component in the attenuation of neurotoxic oxidative stress.
The half-life (t 1/2 ) of the trialkyltins is dependent upon the accumulation of tin species within the CNS. Triethyltin (TET) concentrations in the brain following a single i.v. injection of the chloride salt decreased by 60% between 24 h and 5 days, corresponding to a t 1/2 of approximately 4 days (Rose and Aldridge, 1968) . TET completely disappeared from the CNS with a t 1/2 of 12 days upon cessation of chronic exposure (Cremer, 1957) . The clearance of TMT from the CNS appears to be much slower, with a calculated t 1/2 of approximately 16 days (Brown et al., 1979) . The cellular distributions of TMT and TET in the CNS have not been extensively studied. The exposure of rats to TMT results in lower concentrations but greater persistence of tin in subcellular fractions, compared with the exposure to TET (Cook et al., 1984) . Additionally, there is delayed accumulation of tin in the mitochondrial fraction following Fig. 8 . Photomicrographs of Cresyl Violet-stained sections 3 weeks after TMT administration. Hippocampal tissues from rats treated with saline (A) or ascorbate had clearly visible neuronal layers after Cresyl Violet-staining. There was a significant loss of neurons in the pyramidal layer after TMT administration (B). Prolonged treatment with ascorbate (50 mg/kg, p.o.) significantly attenuated this neuronal loss (C). The neuroprotective effect was more pronounced in the animal that received a higher dose of ascorbate (100 mg/kg, p.o.) (D). Each scale barϭ250 m. The percentage of surviving neurons in the SP was calculated using an image analysis system (Kim et al., 1999a; Shin et al., 2004 Shin et al., , 2005 TMT but not TET exposure. In this study, we cannot rule out the possibility that ascorbate may facilitate the excretion of TMT and/or affect permeability to TMT of the bloodbrain barrier for its entry into the brain. Little information is available about the regional distribution of alkyltin or about the relative rates and sites of cleavage of tin-carbon bonds.
Our immunocytochemical analysis clearly demonstrated a decrease in the level of glutathione reactivity in pyramidal neurons before the detection of histological signs of neuronal death, whereas the glutathione-like immunoreactivity was induced in the proliferating glialike cells by 3 weeks post-TMT. This suggests that the synthesis of glutathione differs among the cell types subject to the TMT insult and the glial induction of glutathione synthesis reflects an adaptive defense against oxidative stress. Double-label immunostaining for glutathione and GFAP showed a co-localization of the two antigens in reactive astrocytes, suggesting that glutathione was specifically induced in this particular type of glial cell in response to neuronal injury. As ascorbate treatment significantly attenuated the proliferation of the glutathione-immunoreactive astrocytes in this study, we raise the possibility that glutathionepositive reactive astrocytes may take part in a compensative mechanism against the TMT-induced elimination of glutathione-immunoreactive pyramidal neurons owing to neuronal degeneration. However, the significance of the induction of glutathione synthesis in reactive astroglial cells following TMT insult remains to be clarified.
In summary, the systemic administration of TMT resulted in initial oxidative stress, seizures, and a persistent disruption of glutathione homeostasis in the rat brain. Given that ascorbate treatment significantly attenuated these alterations, early oxidative stress induced by TMT, leading to a persistent deficiency in glutathione status, may be a cause of the neural damage attributable to this toxin.
